Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers By Koneksa HealthNews NEW YORK– (BUSINESS WIRE) – Koneksa, the evidence-based digital biomarkers company, announced today a partnership with Beacon Biosignals, the leading computational neurodiagnostics company, to launch a clinical trial to investigate...Read More June 13, 2023
